Sarah Oliai

Cooley advised Infleqtion, a global leader in neutral atom-based quantum technology, on its definitive business combination agreement with Churchill Capital Corp X, with the aim to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.

Cooley advised Wugen, a clinical-stage biotechnology company pioneering the next generation of allogeneic, off-the-shelf chimeric antigen receptor T-cell (CAR-T) therapies, on its $115 million Series C financing.

Cooley advised Indian conglomerate Reliance Industries on its joint venture with Meta that will build and scale enterprise artificial intelligence solutions for enterprises in India and select international markets.

Cooley advised Group14 Technologies, a global leader in advanced silicon battery materials, on the close of its $463 million Series D financing and acquisition of its joint venture with SK, Inc.

Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $96 million initial public offering (IPO).